Teva- Pharmaceutical Industries Ltd. - ADR

TEVA

Market Cap$15.78B

Close$

Compare Teva- Pharmaceutical Industries Ltd. - ADR

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Teva- Pharmaceutical Industries Ltd. - ADR	-28.3	0%	-7%	1	2.6
Market Avg	58.2	1.29%	31%	-	1
Healthcare Avg	64	1.3%	15%	-	0.9

$19.00

Target Price by Analysts

34.9% upsideTeva- Pharmaceutical Industries Ltd. - ADR Target Price Details

$-3.98

Current Fair Value

128.3% downside

Overvalued by 128.3% based on the discounted cash flow analysis.

Share Statistics

Market cap	$15.78 Billion
Enterprise Value	$32.39 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-0.5
Beta	0.51
Outstanding Shares	1,120,992,397
Avg 30 Day Volume	9,218,457

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-28.29
PEG	20.91
Price to Sales	1.01
Price to Book Ratio	2.35
Enterprise Value to Revenue	2.04
Enterprise Value to EBIT	10.13
Enterprise Value to Net Income	-59
Total Debt to Enterprise	0.61
Debt to Equity	2.64

Revenue Sources

No data

ESG Score

No data

About Teva- Pharmaceutical Industries Ltd.

CEO: Kaare Schultz